Time to evolve: predicting engineered T cell-associated toxicity with next-generation models
Sign Up to like & getrecommendations! Published in 2022 at "Journal for Immunotherapy of Cancer"
DOI: 10.1136/jitc-2021-003486
Abstract: Despite promising clinical results in a small subset of malignancies, therapies based on engineered chimeric antigen receptor and T-cell receptor T cells are associated with serious adverse events, including cytokine release syndrome and neurotoxicity. These… read more here.
Keywords: engineered cell; cell; evolve predicting; predicting engineered ... See more keywords